Clinical Trials Logo
  1. Home
  2. Eczema
  3. NCT02381028

Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children

Atopic Eczema Clinical Trial

Official title:
Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children: A Small, Randomized, Split Body, Controlled, Blinded Pilot Study

Clinical Trial Summary

The aim of this small pilot study is to assess the potential effects and risks of applying fresh human milk locally on eczema spots in children with atopic eczema. This is a split body, controlled, randomized and physician blinded pilot study, of children with atopic eczema with two similar contralateral eczema spots having a mother breastfeeding the child or a sibling. Fresh expressed milk and emollient is to be applied on the intervention spot and emollient alone on the control area, three times a day for four weeks. Severity and area of the eczema spots is evaluated weekly, and samples from milk and the spots were analysed weekly with respect to bacterial colonisation.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02381028
Study type Interventional
Source Oslo University Hospital
Contact
Status Completed
Phase N/A
Start date October 2008
Completion date November 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00484003 - A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis Phase 4
Recruiting NCT06230991 - A Pilot Study of Efficacy and Safety of SIM05 in Adults With Atopic Eczema N/A
Recruiting NCT05454722 - A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema. N/A
Completed NCT01854580 - Evaluation of an Integrated Care Project
Completed NCT00555178 - Regulatory T Cells (Tregs) in Polymorphic Light Eruption N/A
Completed NCT00559546 - Montelukast as a Controller of Atopic Syndrome Phase 4
Completed NCT00224432 - Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis N/A
Active, not recruiting NCT03143504 - A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) Study
Active, not recruiting NCT03409367 - A Community-based Assessment of Skin Care, Allergies, and Eczema N/A
Completed NCT00826592 - Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis N/A
Completed NCT00576238 - Skin Tolerance Study of Betamethasone Creams in Atopic Eczema and the Preventative Properties of a Moisturiser Phase 3
Recruiting NCT05590585 - Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial Phase 4
Completed NCT01119313 - Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema Phase 2
Completed NCT00676884 - A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema Phase 2
Recruiting NCT03270566 - Softened Water for Eczema Prevention Pilot Trial N/A
Completed NCT02300701 - Role of Anti-IgE in Severe Childhood Eczema Phase 4
Completed NCT04114097 - The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover Phase 4
Completed NCT02915146 - Narrowband Ultraviolet B Versus Narrowband Ultraviolet B Plus Ultraviolet A1 for Atopic Eczema N/A
Recruiting NCT00771121 - Effect of Moisturizing Creams on Skin Barrier Function Phase 4
Completed NCT01179529 - Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage Phase 2